
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter H - Medical Devices
#### PART 892 - RADIOLOGY DEVICES
##### Subpart B - Diagnostic Devices
###### ยง 892.1990 Transilluminator for breast evaluation.
####### Date premarket approval (PMA) or notice of completion of product development protocol (PDP) is required.

(c)A PMA or notice of completion of a PDP is required to be filed with FDA by April 17, 2014, for any transilluminator for breast evaluation that was in commercial distribution before May 28, 1976, or that has, by April 17, 2014, been found to be substantially equivalent to any transilluminator for breast evaluation that was in commercial distribution before May 28, 1976. Any other transilluminator for breast evaluation shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.
